Lanosterol 14α-demethylases (hemoproteins of the cytochrome P450(51) family) are involved in biosynthesis of different membrane sterols, including animal cholesterol, fungal ergosterol and C24-modified plant and protozoa sterols. In this study we have investigated 10 structural analogs of lanosterol isolated from echinoderms belonging to the class Asteroidea as potential ligands (competitive inhibitors) of human and Candida albicans cytochromes P450(51). The study was performed using the surface plasmon resonance method, spectrophotometric titration and enzyme assay. Among the compounds tested we found several selective ligands for human and Candida albicans cytochromes. Between selective ligands of the human lanosterol 14α-demethylase we found two novel inhibitors of this enzyme: henricioside Н 1 and levisculoside G from Henricia derjugini. With due consideration of obtained data, we conclude that marine organisms from the class Asteroidea can be a valuable source of new lead compounds for creation of selective inhibitors of cytochromes P450(51) family with less side effects due to their selective action on these enzymes in different types of organisms.
Lanosterol 14α-demethylases (hemoproteins of the cytochrome P450(51) family, CYP51) are involved in biosynthesis of different membrane sterols, including animal cholesterol, fungal ergosterol and C24-modified plant and protozoa sterols. They catalyze oxidative removal of the α-methyl group at C14 atom in the sterol structure [1] . Human CYP51 represents an attractive target in the development of new anti-atherosclerotic drugs that reduce cholesterol levels in the body by blocking the latter stages of cholesterol biosynthesis. One can expect that such compounds would exhibit fewer side effects than currently used statins [2] , which block hydroxymethylglutaryl-CoA reductase, the key enzyme catalyzing one of the initial reactions of endogenous cholesterol synthesis. Inhibition of this enzyme, however, leads to severe side effects, such as skeletal myopathy, rhabdomyolysis and hepatic insufficiency [3] . On the other hand, CYP51s are considered as targets for pharmacological agents that can block synthesis of endogenous sterols needed for building membrane structures of pathogen microorganisms. Today cytochromes P450 inhibitors from the azole class are currently used for treatment of fungal infections [4] ; they have a broad spectrum of actions on the enzymes of different CYP families of P450 thus causing various side effects [5] .
At the same time, various pathogens of the genus Candida that cause fungal infections are azole-resistant [4] . In this context CYP51 of these fungi could be a promising target for the development of new selective antifungal agents effective against azole-resistant fungal infections. Earlier there were attempts to create selective CYP51 inhibitors based on structural analogs of substrates that would be free of toxic effects typical for statins and azoles [6] [7] [8] [9] [10] [11] ; however, such compounds have not been implemented in clinical practice so far.
For screening of potential inhibitors of CYP51 we have previously developed a test system based on a Biacore 3000 (GE Healthcare, USA) biosensor, operating on the surface plasmon resonance effect (SPR) [12] . It has been successfully used for finding potential inhibitors of human CYP51 among triterpene glycosides of plant and animal origin [13] . In this study, we have applied this approach to find potential inhibitors of human CYP51 (CYP51hum) and CYP51 from azole-resistant strain of Candida albicans (CYP51can). Search was carried out among structural analogues of lanosterol isolated from marine organisms Asteroidea class. Their interaction with CYP51 members has not been previously studied. Seven new compounds that interact with the active site of target cytochromes P450 were detected. By the data of the spectrophotometric titration (ST) one of them are selective for human CYP51 and four others -for CYP51 of Candida albicans. And the ability of two compounds (henricioside Н 1 and levisculoside G from Henricia derjugini) to inhibit the activity of human CYP51 were verified by the enzyme assay. (see Figure 1 ) with CYP51hum and CYP51can, immobilized on the surface of the optical chip, was performed using the concentration of each test compound of 30 µM (see Figure 2 ). Figure 2 shows that compounds 3 and 8 did not interact with immobilized cytochromes P450. Remaining eight compounds formed complexes with CYP51hum and CYP51can. Varying concentrations of the compounds tested we determined the values of equilibrium dissociation constants (Kd), which varied from 0.34 µM to 12.5 µM (see Table 1 ). Among the compounds tested there were several selective ligands for human CYP51 (Kd ratios for human:fungal CYP51 of 0.15 and 0.25) and Candida albicans CYP51 (Kd ratios for human:fungal CYP51 of 6.22 and 12.28), respectively.
Surface plasmon resonance and Spectrophotometric titration
However, optical biosensor responds to all types of ligand contacts with the surface of the enzyme and cannot indicate that the compound can bind at the enzyme active site and thus influence its function.
To confirm the ability of tested compounds to bind to the CYP51's active site and modify the spin state of the heme iron atom, we have performed a spectrophotometric titration (ST) study.
Using the method of ST we have found compounds that can interact with the CYP51hum (compounds 5, 6, 7) and CYP51can (compounds 2, 5, 7, 9, 10, 11) active site. It is interesting that the compound 7 showed spectral changes with both of the enzymes interact with CYP51hum far more specific than with CYP51can (ST Kd ratio is 0,02). The same data was shown for compound 5 (except it was more specific to CYP51can with ST Kd ratio 25.67). It should be noted that the Kd values obtained using the optical biosensor for CYP51s complexes with of low molecular weight compounds differ from the Kd values obtained during the spectrophotometric titration experiments. These differences can be attributed to different tightness of resultant complexes formed in solution and on the surface of the optical chip; it is also possible that ligands may interact with various sites of the enzyme molecule. [15] .
Considering that fact we could suggest that G-307-C mutation in the CYP51can substrate recognition sites of 4 [16] could prevent the interaction between lanosterol and CYP51can substrate binding domain. But of course this statement needs the experimental evidence.
Inhibitors of lanosterol 14α-demethylases
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It was shown for the first time that compounds 5 and 6 inhibit the activity of the CYP51hum. Despite the IC50 were not determined during experiments it could be roughly estimated as 80-90 µM for both compounds. Hence we have found several sterol structures which could be used for future drug design experiments. With due consideration of obtained data, we conclude that marine organisms from the class Asteroidea can be a valuable source of new lead compounds for creation of selective inhibitors of cytochromes P450(51) family with less side effects due to their selective action on these enzymes in different types of organisms.
Experimental
General Experimental Procedures: cDNA for protein expression was isolated using "DNA-VK" kit of reagents for DNA isolation developed in the SSI Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus. The isolation of the steroid compounds was performed using the chromatographic complex Agilent 1100 (Agilent, USA). The SPR study of intermolecular interactions was performed using the optical biosensor Biacore 3000 (GE Healthcare, USA). Refractive indexes of compound samples and solvent contained run buffer were measured using a precision refractometer RX-5000 (ATAGO, Japan). UV-vis spectra were obtained using Shimadzu UV3000 (Shimadzu Corp., Japan) spectrophotometer. Enzyme assay was performed using Acella HPLC system (Thermo Fisher, USA) directly coupled to an LCQ Fleet ion trap mass spectrometer (Thermo Fisher, USA) equipped with an atmospheric pressure chemical ionization source. The following reagents were obtained from manufacturer: HBS-N buffer (150 mM NaCl, 10 mM HEPES, pH 7.4), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide-HCl (EDC), N-hydroxysuccinimide (NHS), 10 mM acetate buffer (pH 5.0), 1 M ethanolamine-HCl (pH 8.5) (GE Healthcare, USA), Ni-NTA-agarose (Qiagen, USA), Bacto-Tryptone, Bacto-Peptone and Bacto-Yeast extract (Difco Laboratories, USA), Bio-Gel HTP (Bio-Rad, USA). Others analytical grade reagents were obtained from local suppliers.
Proteins:
Highly purified (>95% purity according to SDS electrophoresis in 12% PAAG) recombinant cytochromes P450(51) of human and Candida albicans were expressed in E. coli (DH_5α strain) transformed with plasmid DNA carrying cDNA fragments of proteins of interest and isolated and purified as described previously [14, 16] . CYP51can cDNA samples were isolated in the Belarussian research center for pediatric oncology, hematology and immunology (Ministry of Health of the Republic of Belarus) from a clinical sample, exhibiting resistance to antifungal drugs, and were used for obtaining CYP51can. Four amino acid substitutions (K-179-E, L-224-I, G-307-C, M-372-T) were found in the CYP51can amino acid sequence [16] .
Steroid compounds:
The used steroid compounds -lanosterol (a natural substrate for both of the enzymes [17] and its structural analogues, isolated from the several species of starfishes, -are summarized in the Figure 1 .
Lanosterol (1) was obtained from Sigma-Aldrich (USA). Steroid compounds 2-11 were isolated from starfishes. Compounds 2-10 were isolated and purified according to the procedures published previously [18] [19] [20] [21] [22] [23] . Compound 11 was obtained by the following original protocol. Fresh samples of the starfish Archaster typicus (the total weight 7 kg) were chopped and extracted three times with ethanol at 20 °C. Hydroalcoholic extract was evaporated and the resulting dry residue was dissolved in 1 liter of water. The resulting solution was passed through a chromatography column (7×26 cm) packed with sorbent Polychrome 1 and the column was then washed with water until a negative chloride ion reaction. After this a steroid fraction was eluted from the column with ethanol. The combined ethanol eluate was evaporated to give a brownish material (the total weight 29.7 g). The resulting total fraction of steroid compounds was chromatographed on a silica gel column (6.5×20 cm) using gradient of chloroform/ethanol mixture (gradient was changed stepwise from 4:1 to 1:6) and the total fraction of asterosaponins was obtained. The fraction of asterosaponins (the total weight 323 mg) was separated by HPLC on a Diasfer-110-C18 column (10 micron, 250×15 mm, 2.5 mL/min) using ethanol/water/1M ammonium acetate (55:44:1 v/v) as the mobile phase. As a result, the pure compound 11 was obtained (the total weight 57.9 mg, tR 21.0 min), which was identified by comparison of its 1 H and 13 C NMR with those reported for thornasteroside A [24, 25] .
SPR analysis
Immobilization of CYP51 on surface of the optical chip CM5 and compound samples preparation were performed according to the procedures published previously [13] . Analysis of test compounds interactions with the immobilized CYP51 were performed by injection of their 30 µM solutions in 360 sec at a flow rate of 10 µL/min. To determine the equilibrium dissociation constant of complexes (Kd) a sets of sensorgrams were obtained by injection of test compounds solutions for 360 sec at a flow rate of 10 µL/min in the range of 10-100 µM concentrations. Dissociation of the complexes was recorded for at least 360 sec. The sensor chip surface was regenerated by injections of the regenerating solution (2M NaCl, 0.4% m/v CHAPS) for 17 sec at a flow rate 35 µL/min. All experiments were performed at 25°C. Kd values were calculated from sensorgrams sets using software BIAevaluation v.4.1 (GE Healthcare, USA). Kd mean values and standard errors were obtained from at least three experiments.
Spectrophotometric titration:
Ligand-induced spectral changes were analyzed using spectrophotometric titration as a shift of the heme Soret peak according to the procedures published previously [13] . Lanosterol was added to the maximum concentration of 50 M and compounds were added to the maximum concentration of 33.4 M.
Enzyme assay:
The 14α-demethylase activity of CYP51hum was measured in the reconstituted system according to the procedure published previously [14] . Compounds (dissolved in EtOH) were added to a concentration of 1, 10, 50 μМ. CYP51hum reaction product ratio with and without addiction of the test compounds was measured according to Trosken et al. [26] . Mean values and standard errors were obtained from at least three experiments.
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